Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes

Trends in Biochemical Sciences

Volumn 38, Issue 1, 2013, Pages 3-11

  Wong, Brian W ^a,b   Kuchnio, Anna ^a,b   Bruning, Ulrike ^a,b   Carmeliet, Peter ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Glycolysis; Hypoxia inducible factor; Metabolism; Oxygen sensing; Prolyl hydroxylase domain enzymes

Indexed keywords

AMPA RECEPTOR; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PYRUVATE KINASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UNCLASSIFIED DRUG;

BINDING AFFINITY; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; ENANTIOMER; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; HYDROXYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVASCULARIZATION; REVIEW; SYNAPTIC TRANSMISSION; WOUND HEALING;

ANIMALS; ANOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXYGEN; PROCOLLAGEN-PROLINE DIOXYGENASE; SIGNAL TRANSDUCTION;

EID: 84871475998     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2012.10.004     Document Type: Review

References (89)

1. Lieb M.E., et al. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem. Cell Biol. 2002, 80:421-426.
2. Aragones J., et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 2008, 40:170-180.
3. Schneider M., et al. Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury. Gastroenterology 2010, 138:1143-1154.
4. Takeda K., et al. Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol. Cell Biol. 2006, 26:8336-8346.
5. Takeda K., et al. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 2007, 116:774-781.
6. Minamishima Y.A., et al. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 2008, 111:3236-3244.
7. Bishop T., et al. Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice. Mol. Cell Biol. 2008, 28:3386-3400.
8. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
9. Aragones J., et al. Oxygen sensors at the crossroad of metabolism. Cell Metab. 2009, 9:11-22.
10. Coulon C., et al. From vessel sprouting to normalization: role of the prolyl hydroxylase domain protein/hypoxia-inducible factor oxygen-sensing machinery. Arterioscler Thromb. Vasc. Biol. 2010, 30:2331-2336.
11. Kaelin W.G. Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:335-345.
12. Fong G.H., Takeda K. Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 2008, 15:635-641.
13. Barth S., et al. Hypoxia-inducible factor prolyl-4-hydroxylase PHD2 protein abundance depends on integral membrane anchoring of FKBP38. J. Biol. Chem. 2009, 284:23046-23058.
14. Nakayama K., et al. Hypoxia-induced assembly of prolyl hydroxylase PHD3 into complexes: implications for its activity and susceptibility for degradation by the E3 ligase Siah2. Biochem. J. 2007, 401:217-226.
15. Chowdhury R., et al. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure 2009, 17:981-989.
16. Lee K., et al. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17910-17915.
17. Zhang N., et al. The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism. Cell Metab. 2010, 11:364-378.
18. Selak M.A., et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005, 7:77-85.
19. Hewitson K.S., et al. Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. J. Biol. Chem. 2007, 282:3293-3301.
20. Lu H., et al. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem. 2002, 277:23111-23115.
21. Zhao S., et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 2009, 324:261-265.
22. Dang L., et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009, 462:739-744.
23. Prensner J.R., Chinnaiyan A.M. Metabolism unhinged: IDH mutations in cancer. Nat. Med. 2011, 17:291-293.
24. Koivunen P., et al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 2012, 483:484-488.
25. Chowdhury R., et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 2011, 12:463-469.
26. Figueroa M.E., et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010, 18:553-567.
27. Xu W., et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 2011, 19:17-30.
28. Carmeliet P., et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998, 394:485-490.
29. Acker T., et al. Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell 2005, 8:131-141.
30. Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr. Opin. Cell Biol. 2009, 21:894-899.
31. Niecknig H., et al. Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia. Free Radic. Res. 2012, 46:705-717.
32. Masson N., et al. The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity. EMBO Rep. 2012, 13:251-257.
33. Schofield C.J., Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 2004, 5:343-354.
34. Adam J., et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 2011, 20:524-537.
35. Nytko K.J., et al. Vitamin C is dispensable for oxygen sensing in vivo. Blood 2011, 117:5485-5493.
36. Tennant D.A., Gottlieb E. HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression. J. Mol. Med. (Berl.) 2010, 88:839-849.
37. Vander Heiden M.G., et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 2010, 329:1492-1499.
38. Yang W., et al. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 2011, 480:118-122.
39. Gao X., et al. Pyruvate kinase m2 regulates gene transcription by acting as a protein kinase. Mol. Cell 2012, 45:598-609.
40. Christofk H.R., et al. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 2008, 452:181-186.
41. Christofk H.R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
42. Hitosugi T., et al. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci. Signal. 2009, 2:ra73.
43. Luo W., et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011, 145:732-744.
44. Shi H., et al. A cytosolic iron chaperone that delivers iron to ferritin. Science 2008, 320:1207-1210.
45. Nandal A., et al. Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2. Cell Metab. 2011, 14:647-657.
46. Chaudhury A., et al. TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat. Cell Biol. 2010, 12:286-293.
47. Kosturko L.D., et al. Heterogeneous nuclear ribonucleoprotein (hnRNP) E1 binds to hnRNP A2 and inhibits translation of A2 response element mRNAs. Mol. Biol. Cell 2006, 17:3521-3533.
48. Pesti T., et al. Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping. Hum. Pathol. 2001, 32:101-104.
49. Mazzone M., et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009, 136:839-851.
50. Leite de Oliveira R., et al. Gene-targeting of phd2 improves tumor response to chemotherapy and prevents side-toxicity. Cancer Cell 2012, 22:263-277.
51. Percy M.J., et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:654-659.
52. Cummins E.P., et al. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18154-18159.
53. Fu J., Taubman M.B. Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway. J. Biol. Chem. 2010, 285:8927-8935.
54. Xue J., et al. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Gastroenterology 2010, 138:606-615.
55. Takeda Y., et al. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 2011, 479:122-126.
56. Park E.C., et al. Hypoxia regulates glutamate receptor trafficking through an HIF-independent mechanism. Embo. J. 2012, 31:1379-1393.
57. Ma D.K., et al. CYSL-1 interacts with the O(2)-sensing hydroxylase EGL-9 to promote H(2)S-modulated hypoxia-induced behavioral plasticity in C. elegans. Neuron 2012, 73:925-940.
58. Caraci F., et al. Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?. Neurochem. Int. 2012, 61:559-565.
59. Takahashi N., et al. TRPA1 underlies a sensing mechanism for O2. Nat. Chem. Biol. 2011, 7:701-711.
60. Clapham D.E. TRP channels as cellular sensors. Nature 2003, 426:517-524.
61. Voets T., et al. Sensing with TRP channels. Nat. Chem. Biol. 2005, 1:85-92.
62. Yoshida T., et al. Nitric oxide activates TRP channels by cysteine S-nitrosylation. Nat. Chem. Biol. 2006, 2:596-607.
63. Xu S.Z., et al. TRPC channel activation by extracellular thioredoxin. Nature 2008, 451:69-72.
64. Foxler D.E., et al. The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity. Nat. Cell Biol. 2012, 14:201-208.
65. Callapina M., et al. NO restores HIF-1alpha hydroxylation during hypoxia: role of reactive oxygen species. Free Radic. Biol. Med. 2005, 39:925-936.
66. Fedotcheva N.I., et al. Nonezymatic formation of succinate in mitochondria under oxidative stress. Free Radic. Biol. Med. 2006, 41:56-64.
67. Hyvarinen J., et al. Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury. J. Biol. Chem. 2010, 285:13646-13657.
68. Chua Y.L., et al. Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production. J. Biol. Chem. 2010, 285:31277-31284.
69. Semenza G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, 2007:cm8.
70. Ameln A.K., et al. Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFbeta. Cancer Res. 2011, 71:3306-3316.
71. Hiwatashi Y., et al. PHD1 interacts with ATF4 and negatively regulates its transcriptional activity without prolyl hydroxylation. Exp. Cell Res. 2011, 317:2789-2799.
72. Koditz J., et al. Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood 2007, 110:3610-3617.
73. Sato M., et al. Human PRP19 interacts with prolyl-hydroxylase PHD3 and inhibits cell death in hypoxia. Exp. Cell Res. 2010, 316:2871-2882.
74. Yan B., et al. Prolyl hydroxylase domain protein 3 targets Pax2 for destruction. Biochem. Biophys. Res. Commun. 2011, 409:315-320.
75. Anderson K., et al. Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins. J. Biol. Chem. 2011, 286:42027-42036.
76. Masson N., et al. The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin. FEBS Lett. 2004, 570:166-170.
77. Baek J.H., et al. OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha. Mol. Cell 2005, 17:503-512.
78. Choi Y.K., et al. AKAP12 regulates human blood-retinal barrier formation by downregulation of hypoxia-inducible factor-1alpha. J. Neurosci. 2007, 27:4472-4481.
79. Hopfer U., et al. The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3). J. Biol. Chem. 2006, 281:8645-8655.
80. Ozer A., et al. The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7481-7486.
81. Huang J., et al. IOP1, a novel hydrogenase-like protein that modulates hypoxia-inducible factor-1alpha activity. Biochem. J. 2007, 401:341-352.
82. Aprelikova O., et al. Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response. Cancer Res. 2009, 69:616-624.
83. Balamurugan K., et al. Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response. Oncogene 2009, 28:3274-3285.
84. Fu J., et al. EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability. J. Biol. Chem. 2007, 282:12410-12418.
85. Schlisio S., et al. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 2008, 22:884-893.
86. Mikhaylova O., et al. The von Hippel-Lindau tumor suppressor protein and Egl-9-type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress. Mol. Cell Biol. 2008, 28:2701-2717.
87. Xie L., et al. Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci. Signal. 2009, 2:ra33.
88. Xie L., et al. PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response. J. Clin. Invest. 2012, 122:2827-2836.
89. Huo Z., et al. Prolyl hydroxylase domain protein 2 regulates the intracellular cyclic AMP level in cardiomyocytes through its interaction with phosphodiesterase 4D. Biochem. Biophys. Res. Commun. 2012, 427:73-79.